Evidence map›Paper›PMID 33053434›Full record

ArticleBrain research bulletin2020

Evidence of early vasogenic edema following minor head impact that can be reduced with a vasopressin V1a receptor antagonist.

Praveen Kulkarni, Mansi R Bhosle, Shi-Fang Lu, Neal S Simon, Sade Iriah, Michael J Brownstein, Craig F Ferris

Open access · greenAbstract read
In one paragraph

Article in Brain research bulletin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Praveen KulkarniCenter for Translational Neuroimaging, Northeastern Univ, Boston, MA, United States.
Mansi R BhosleCenter for Translational Neuroimaging, Northeastern Univ, Boston, MA, United States.
Shi-Fang LuAzevan Pharmaceuticals, Bethlehem, PA, United States; Dept.of Biological Sciences, Lehigh University, Bethlehem, PA, United States.
Neal S SimonAzevan Pharmaceuticals, Bethlehem, PA, United States; Dept.of Biological Sciences, Lehigh University, Bethlehem, PA, United States.
Sade IriahCenter for Translational Neuroimaging, Northeastern Univ, Boston, MA, United States.
Michael J BrownsteinAzevan Pharmaceuticals, Bethlehem, PA, United States.
Craig F FerrisCenter for Translational Neuroimaging, Northeastern Univ, Boston, MA, United States; Departments of Psychology and Pharmaceutical Sciences, Northeastern University, Boston, MA, United States. Electronic address: c.ferris@northeastern.edu.
Northeastern University · USAzevan Pharmaceuticals (United States) · US

Funding

A New Drug for the Treatment of Traumatic Brain InjuryR43NS110343 · NINDS · AZEVAN PHARMACEUTICALS, INC. · PI BROWNSTEIN, MICHAEL J · 2019 to 2019
$501k
NINDS NIH HHS R43 NS110343
6 · The paper itself

Abstract

backgroundDoes minor head impact without signs of structural brain damage cause short-term changes in vasogenic edema as measured by an increase apparent diffusion coefficient (ADC) using diffusion weighted imaging? If so, could the increase in vasogenic edema be treated with a vasopressin V1a receptor antagonist? We hypothesized that SRX251, a highly selective V1a antagonist, would reduce vasogenic edema in response to a single minor head impact.

methodsLightly anesthetized male rats were subjected to a sham procedure or a single hit to the forehead using a closed skull, momentum exchange model. Animals recovered in five min and were injected with saline vehicle (n = 8) or SRX251 (n = 8) at 15 min post head impact and again 7-8 hrs later. At 2 h, 6 h, and 24 h post injury, rats were anesthetized and scanned for increases in ADC, a neurological measure of vasogenic edema. Sham rats (n = 6) were exposed to anesthesia and scanned at all time points but were not hit or treated. Images were registered to and analyzed using a 3D MRI rat atlas providing site-specific data on 150 different brain areas. These brain areas were parsed into 11 major brain regions.

resultsUntreated rats with brain injury showed a significant increase in global brain vasogenic edema as compared to sham and SRX251 treated rats. Edema peaked at 6 h in injured, untreated rats in three brain regions where changes in ADC were observed, but returned to sham levels by 24 h. There were regional variations in the time course of vasogenic edema and drug efficacy. Edema was significantly reduced in cerebellum and thalamus with SRX251 treatment while the basal ganglia did not show a response to treatment.

conclusionA single minor impact to the forehead causes regional increases in vasogenic edema that peak at 6 h but return to baseline within a day in a subset of brain regions. Treatment with a selective V1a receptor antagonist can reduce much of the edema.

Indexed as

AnimalsAntidiuretic Hormone Receptor AntagonistsBrainBrain EdemaDisease Models, AnimalHead Injuries, ClosedMagnetic Resonance ImagingMaleRatsRats, Sprague-DawleyAntidiuretic Hormone Receptor AntagonistsApparent diffusion coefficientCerebellumDiffusion weighted imagingMagnetic resonance imagingTraumatic brain injury

Identifiers

PMID33053434
PMCPMC7674251
OpenAlexW3092269878

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.